Shortage in prescription drug supply possible

Posted in Latest News on January 19, 2017.

The DEA recently suspended McKesson Corporation’s sales of controlled substances from distribution in Florida. This suspension could impact your patients’ ability to fill their prescriptions and you may want to advise them about the potential implications. As a practitioner, you should be aware of the possibility of drug shortages and consider alternative treatment options when prescribing controlled substances. As always, use your best professional judgment when caring for your patients.

Please see the link to the news release below: https://www.dea.gov/divisions/hq/2017/hq011717.shtml



More Latest News

Imagineering the Future of Pharmacy Regulation
February 17, 2017

The boards of pharmacy will elect officers and members of the NABP Executive Committee, review and vote on NABP policies, and guide the direction of the Association Continue reading


Shortage in prescription drug supply possible
January 19, 2017

McKesson Corporation will suspend sales of controlled substances from distribution centers in Florida for multiple years. Continue reading